Show
Sort by
-
- Journal Article
- A1
- open access
Targeted AURKA degradation : towards new therapeutic agents for neuroblastoma
-
- Journal Article
- A1
- open access
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
-
RRM2 enhances MYCN driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
-
The RRM2-PHF6 complex protects neuroblastoma cells from DNA damage accumulation to install a replication stress resistance phenotype
-
The H3K27me3 demethylase UTX is a tumor suppressor in T-cell acute lymphoblastic leukaemia